Hovhannisyan, Yeranuhi
Li, Zhenlin
Callon, Domitille
Suspène, Rodolphe
Batoumeni, Vivien
Canette, Alexis
Blanc, Jocelyne
Hocini, Hakim
Lefebvre, Cécile
El-Jahrani, Nora
Kitsara, Maria
L’honoré, Aurore
Kordeli, Ekaterini
Fornes, Paul
Concordet, Jean-Paul
Tachdjian, Gérard
Rodriguez, Anne-Marie
Vartanian, Jean-Pierre
Béhin, Anthony
Wahbi, Karim
Joanne, Pierre
Agbulut, Onnik http://orcid.org/0000-0003-1923-8871
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-21-CE19-0027)
AFM-Téléthon (22142, 20479)
Association Nationale de la Recherche et de la Technologie (2020/0074)
Article History
Received: 3 October 2023
Accepted: 18 December 2023
First Online: 2 January 2024
Declarations
:
: All the iPSC lines used in this study were generated from peripheral blood mononuclear cells (PBMC). Informed consent (written by Phenocell SAS (Grasse, France)) was obtained for the use of these PBMC and their derivatives for research in an anonymized way. This project (title: hiPSC4DCM) was carried out within the framework of a ministerial ethics approval that was obtained from the French Ministry for Research, Higher Education and Innovation (Name of the institutional approval committee or unit: French Ministry for Research, Higher Education and Innovation; Approval number: AC-2019-3388; Date of approval: 29 May 2019). Moreover, the post-mortem heart samples from the patients were obtained after anonymization by the Platform Center of Biological Resources of the Department of Pathology (Academic Hospital of Reims, France) (approval number: DC-2008-374). For each patient, authorizations to perform autopsy and sampling were obtained from the French Biomedicine Agency.
: Not applicable.
: The authors declare that they have no competing interests.